In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time monitoring, and historical data can aid in optimizing trial design.
“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...
Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include ...
In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, discusses challenges such as high costs and long ...
Phase III HELIOS-B trial found that Amvuttra (vutrisiran) also preserved functional capacity and quality of life in patients ...
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical ...
In this video interview, Kimberly Tableman, founder & CEO, ESPERO, discusses how EDC and EHR data can be streamlined to ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback